On behalf of everyone at G2 Intelligence, thank you for joining us, your colleagues, and a world-class faculty of molecular experts and laboratory business leaders at our new Las Vegas venue for the 8th annual MDx NEXT: Gaining Ground in Molecular Testing and Genomic Medicine.
We trust that this yearís agenda provided timely insights into the key operational and business considerations of genomic medicine, including whatís happening now — and whatís next — especially around realizing molecular diagnostics as a profit source rather than a cost center.
Many thanks also to our distinguished speakers for taking time from their busy schedules to share their expertise and thoroughly cover every aspect of evolving MDx technologies, business challenges and opportunities, legal issues, day-to-day concerns, and attitudes toward molecular diagnostics as it continues to grow in ways that are bringing new challenges and opportunities for labs.
Once again, thank you for being part of G2ís annual MDx NEXT molecular diagnostics conference, the must-attend event for:
- Medical and Administrative Directors
- Laboratory and AP CEOs, COOs, CFOs and GMs
- Business Development Officers
- Chief Science Officers
- Reimbursement, Billing and Coding Personnel
- Chief Technology Officers
- Information Technology Specialists
- Diagnostic Market Analysts
Weíre already in the early planning stages of G2ís ninth annual MDx NEXT. Check back for updates on our 2014 event!